FindTrial
Sign In

Treatment and adverse effects of medications used for sleeplessness in elderly patients

Pharmacotherapy and adverse effects of medications used for insomnia in elderly patients in a tertiary care hospital - A prospective observational study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047378
Enrollment
152
Registered
2022-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F068- Other specified mental disorders due to known physiological condition

Interventions

None listed

Sponsors

Varun Santhosh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Consenting Elderly patients (age >= 65 years, both genders) with physician diagnosed insomnia under medications.

Exclusion criteria

Exclusion criteria: Patients with Delirium, Altered sensorium.

Design outcomes

Primary

MeasureTime frame
Prescription practice and Pattern of use of insomnia medicationsTimepoint: Over a period of 6 weeks—

Secondary

MeasureTime frame
Adverse effects of insomnia medications.Timepoint: Over a period of 6 weeks.;Quality of lifeTimepoint: Over a period of 6 weeks—

Countries

India

Contacts

Public ContactVarun Santhosh

St. Johns Medical College

atiyadoc@gmail.com9980018022

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026